Major enhancement to in vitro testing of human liver-stage malaria

May 9, 2018, University of South Florida
The large green structures are the P. vivax parasites surrounded by human liver cells. Credit: John Adams, PhD, University of South Florida

A newly developed technique allows researchers to more easily study malaria outside the human body during the earliest point of infection, the liver. The liver stage is significant as it precedes the parasite's ability to infect human blood, the point of which symptoms of malaria first appear.

"Almost all of the current strategies are focused the blood-stage of malaria—after the person has already become infected," said lead author John Adams, Ph.D., distinguished professor at the University of South Florida College of Public Health. "But, in order to eradicate this disease, you need to block the cycle of reinfection and the most efficient way to do that is by blocking the parasite from coming into the person. This has not been possible previously because the methods of studying the liver stage have just not been there. Our technique makes that work possible."

In the study published in Nature Communications, researchers used 384-well plates, the standard tool used for analytical lab research, to cultivate primary human , greatly enhancing parasite development rates. This updated in vitro method allows scientists to more quickly screen preclinical drugs and vaccines than current techniques.

"Some of the other methods for researching liver stage malaria are very expensive with large biomaterial requirements," said co-lead author Alison Roth, Ph.D., University of South Florida College of Public Health. "Our method reduces the cost and biomaterials which makes it much more accessible," Roth said. "It's exciting to know that the model we've developed can be easily adapted to other labs and even used in endemic countries."

Dr. Roth says they're now working on a vaccine to prevent the parasite from infecting cells and eventually drugs to kill the parasite once it's entered the .

Explore further: Why some people may not respond to the malaria vaccine

Related Stories

Why some people may not respond to the malaria vaccine

December 20, 2016
Generating protective immunity against the early liver stage of malaria infection is feasible but has been difficult to achieve in regions with high rates of malaria infection. Researchers at the University of Washington ...

Malaria's key to the liver uncovered

July 27, 2015
Scientists uncover a port of liver entry for malaria parasites in a report published in The Journal of Experimental Medicine. If these results hold up in humans, drugs that target this entry protein might help prevent the ...

Recommended for you

Study shows how MERS coronavirus evolves to infect different species

August 14, 2018
In the past 15 years, two outbreaks of severe respiratory disease were caused by coronaviruses transmitted from animals to humans. In 2003, SARS-CoV (severe acute respiratory syndrome coronavirus) spread from civets to infect ...

Inching closer to a soft spot in isoniazid-resistant tuberculosis

August 14, 2018
Antibiotic-resistant tuberculosis is a public health threat. TB and other bacteria become resistant to antibiotics by evolving genetic changes over time, which they can do quite quickly because bacterial lifecycles are short. ...

Why do women get more migraines?

August 14, 2018
Research published today reveals a potential mechanism for migraine causation which could explain why women get more migraines than men. The study, in Frontiers in Molecular Biosciences, suggests that sex hormones affect ...

How long is an Ebola survivor contagious? One case is causing scientists to rethink the answer.

August 14, 2018
Surviving Ebola isn't like getting over the flu.

Link between common 'harmless' virus and cardiovascular damage

August 13, 2018
Researchers from Brighton and Sussex Medical School (BSMS) have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.

Rotavirus vaccine cuts infant diarrhoea deaths by a third in Malawi

August 11, 2018
A major new study has shown that rotavirus vaccination reduced infant diarrhoea deaths by 34% in rural Malawi, a region with high levels of child deaths.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.